Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.57 USD | +2.11% | +7.78% | -39.46% |
23/05 | Earnings Flash (ME) 23ANDME Reports Q4 Revenue $64M, vs. Street Est of $61.5M | MT |
23/05 | 23andMe Q4 Loss Widens, Revenue Decreases | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.46% | 274M | |
-24.16% | 7.66B | |
+68.35% | 4.35B | |
+2.72% | 2.62B | |
-2.98% | 2.53B | |
-46.17% | 2.21B | |
-15.64% | 1.79B | |
-23.00% | 1.48B | |
+13.62% | 1.18B | |
-43.81% | 1.13B |
- Stock Market
- Equities
- ME Stock
- News 23andMe Holding Co.
- 23andMe Unit Offers Petros Pharmaceuticals' Impotency Medication